Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3256-3262

  Speer, Gábor ^a   Fekete, Bertalan Cs ^a   El Hadj Othmane, Taha ^a   Szabó, Tamás ^b   Egresits, József ^a,c   Fodor, Erzsébet ^b   Kiss, István ^b,c   Logan, Alexander G ^d   Nemcsik, János ^b   Szabó, András ^a   Németh, Zsófia K ^a   Szathmári, Miklós ^a   Tislér, András ^a,b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b B Braun Avitum Nephrological Network   (Hungary)

^c Szent Imre Hospital   (Hungary)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cardiovascular mortality; Osteoprotegerin; Pulse wave velocity; Vascular calcification

Indexed keywords

OSTEOPROTEGERIN;

ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULSE WAVE; SURVIVAL;

AGED; BLOOD FLOW VELOCITY; CALCINOSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; COHORT STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MULTIVARIATE ANALYSIS; OSTEOPROTEGERIN; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RENAL DIALYSIS; RISK FACTORS;

EID: 52449129008     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn242     Document Type: Article

References (30)

1. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006; 47: 1027-1034
2. Barreto DV, Barreto FC, Carvalho AB et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremiarelated risk factors. Kidney Int 2005; 67: 1576-1582
3. Caplin B, Wheeler DC. Arterial calcification in dialysis patients and transplant recipients. Semin Dial 2007; 20: 144-149
4. Sigrist M, Bungay P, Taal MW et al.Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714
5. London GM, Gúerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
6. London GM, Marchais SJ, Guerin AP et al. Arterial stiffness: pathophysiology and clinical impact. Clin Exp Hypertens 2004; 26: 689-699
7. London GM, Cohn JN. Prognostic application of arterial stiffness: task forces. Am J Hypertens 2002; 15: 754-758
8. Laurent S, Cockroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605
9. Gusbeth-Tatomir P, Covic A. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 2007; 30: 97-107
10. Raggi P, Bellasi A, Ferramosca E et al. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 2007; 71: 802-807
11. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964
12. Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005; 90: 6323-6331
13. Nitta K, Akiba T, Uchida K. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 2003; 42: 303-309
14. Baber U, de Lemos JA, Khera A et al. Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort. Kidney Int 2008; 73: 615-621
15. Ueland T, Jemtland R, Godang K et al. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1970-1976
16. Morena M, Terrier N, Jaussent I et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol 2006; 17: 262-270
17. Hjelmesaeth J, Ueland T, Flyvbjerg A et al. Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol 2006; 17: 1746-1754
18. Salvi P, Lio G, Labat C et al.Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens 2004; 22: 285-293
19. Bucay N, Sarosi I, Dunstan CR et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268
20. Jono S, Ikari Y, Shioi A et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106: 1192-1194
21. Abedin M, Omland T, Ueland T et al. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol 2007; 99: 513-518
22. Anand DV, Lahiri A, Lim E et al. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol 2006; 47: 1850-1857
23. Mazzaferro S, Pasquali M, Pugliese F et al. Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. Am J Nephrol 2007; 27: 75-83
24. Moe SM, Reslerova M, Ketteler M et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-2304
25. Mezquita-Raya P, de la Higuera M, García DF et al. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Osteoporosis Int 2005; 16: 1368-1374
26. Kim SM, Lee J, Ryu OH et al. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol (Oxf) 2005; 63: 594-598
27. Stompór T, Krzanowski M, Kusnierz-Cabala B et al. Pulse wave velocity and proteins regulating vascular calcification and bone mineralization in patients treated with peritoneal dialysis. Nephrol Dial Transplant 2006; 21: 3605-3606
28. Mahmud A. Reducing arterial stiffness and wave reflection - quest for the holy grail? Artery Research 2007; 1: 13-19
29. London GM, Guérin AP, Verbeke FH et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydrocivitamin D. J Am Soc Nephrol 2007; 18: 613-620
30. Haydar AA, Covic A, Colhoun H et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004; 65: 1790-1794